<p><strong>Adults</strong>: initiate with a dose of 600 mg/day, given twice-a-day</p>

<ul>
	<li><strong>Adjunctive Therapy</strong>: Maximum increment of 600 mg/day at approximately weekly intervals. The recommended daily dose is 1200 mg/day</li>
	<li><strong>Conversion to Monotherapy</strong>: withdrawal concomitant over 3 to 6 weeks;reach maximum dose of Oxcarbazepine in 2 to 4 weeks with increments of 600 mg/day at weekly intervals to a recommended daily dose of 2400 mg/day</li>
	<li><strong>Initiation of Monotherapy</strong>: Increments of 300 mg/day every third day to a dose of 1200 mg/day.</li>
	<li><strong>Creatinine Clearance &lt;30 mL/min</strong>: Initiate at one half the usual starting dose and increase slowly</li>
</ul>

<p><strong>Pediatrics</strong>: initiation with 8 to 10 mg/kg/day, given twice-a-day. For patients aged 2 to &lt;4 years and under 20 kg, a starting dose of 16 to 20 mg/kg/day may be considered. Recommended daily dose is dependent upon patient weight.</p>

<ul>
	<li><strong>Adjunctive Patients (Aged 2&ndash;16 Years)</strong>: For patients aged 4 to 16 years, target maintenance dose should be achieved over 2 weeks. For patients aged 2 to &lt;4 years, maximum maintenance dose should be achieved over 2 to 4 weeks and should not to exceed 60 mg/kg/day</li>
	<li><strong>Conversion to Monotherapy for Patients (Aged 4-16 Years)</strong>: Maximum increment of 10 mg/kg/day at weekly intervals, concomitant antiepileptic drugs can be completely withdrawn over 3 to 6 weeks</li>
	<li><strong>Initiation of Monotherapy for Patients (Aged 4&ndash;16 Years)</strong>: Increments of 5 mg/kg/day every third day</li>
</ul>